Health
Sabari Stresses the Importance of Molecular Testing in Lung Cancer – OncLive
Joshua K. Sabari, MD, discussed the management of patients with early-stage and metastatic lung cancer, the roles of molecular testing, surgery, staging, and ongoing…
Concurrent tissue- and plasma-based testing is needed in all patients to understand tumor heterogeneity, identify potential de novo resistance mutations, and ensure that existing mutations are not missed by potentially false negative results of liquid biopsy, according to Joshua K. Sabari, MD.
Despite all of our advances in lung cancer, unfortunately this disease is often incurable, explained Sabari. Even in the era of immunotherapy, it is critically important to not forget molecular testing. PD-L1…
-
Noosa News19 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General19 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News4 hours agoMotorcyclist dies in crash with truck
-
General21 hours agoPerth man charged after investigation into organised crime and tobacco store attacks